Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (18)

2024

  1. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis

    European Journal of Internal Medicine, Vol. 129, pp. 78-86

  2. Higher Synovial Immunohistochemistry Reactivity of IL-17A, Dkk1, and TGF-β1 in Patients with Early Psoriatic Arthritis and Rheumatoid Arthritis Could Predict the Use of Biologics

    Biomedicines, Vol. 12, Núm. 4

2023

  1. Increased synovial immunohistochemistry reactivity of TGF-β1 in erosive peripheral psoriatic arthritis

    BMC musculoskeletal disorders, Vol. 24, Núm. 1, pp. 246

  2. Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients

    Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 829-836

2022

  1. PROCOAC (PROspective COhort of A Coruña) description: Spanish prospective cohort to study osteoarthritis

    Reumatologia Clinica, Vol. 18, Núm. 2, pp. 100-104

  2. Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients

    Therapeutic Advances in Musculoskeletal Disease, Vol. 14

2020

  1. Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice

    Clinical and experimental rheumatology, Vol. 38, Núm. 2, pp. 112-119

2019

  1. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

    Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 1, pp. 126-135

2010

  1. Validity of the Bath Ankylosing Spondylitis Disease Activity Index for the evaluation of disease activity in axial psoriatic arthritis

    Arthritis Care and Research, Vol. 62, Núm. 1, pp. 78-85

2009

  1. Evaluation of ankylosing spondylitis spinal mobility measurements in the assessment of spinal involvement in psoriatic arthritis

    Arthritis Care and Research, Vol. 61, Núm. 3, pp. 386-392

  2. Genetic variation in the nuclear factor κB pathway in relation to susceptibility to rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 4, pp. 579-583

2008

  1. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis

    Arthritis and Rheumatism, Vol. 58, Núm. 5, pp. 1264-1274

  2. Mitochondrial DNA haplogroups: Role in the prevalence and severity of knee osteoarthritis

    Arthritis and Rheumatism, Vol. 58, Núm. 8, pp. 2387-2396

  3. Polymorphisms in genes encoding tumor necrosis factor-α and HLA-DRB1 are not associated with response to infliximab in patients with rheumatoid arthritis [1]

    Journal of Rheumatology

  4. Prevalence, risk factors, and impact of knee pain suggesting osteoarthritis in Spain

    Clinical and Experimental Rheumatology, Vol. 26, Núm. 2, pp. 324-332

2007

  1. Prevalencia y factores de riesgo de la osteoartritis

    Reumatologia Clinica, Vol. 3, Núm. EXTRA 3, pp. 6-12

2006

  1. Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review

    Osteoarthritis and Cartilage, Vol. 14, Núm. 12, pp. 1306-1311

  2. Estudio ATTAIN: Eficacia del abatacept en pacientes con artritis reumatoide activa y respuesta inadecuada a antagonista de TNF-α

    Reumatologia Clinica Suplementos, Vol. 1, Núm. 2, pp. 34-43